200 related articles for article (PubMed ID: 27965283)
41. LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers.
Yu H; Yue X; Zhao Y; Li X; Wu L; Zhang C; Liu Z; Lin K; Xu-Monette ZY; Young KH; Liu J; Shen Z; Feng Z; Hu W
Nat Commun; 2014 Oct; 5():5218. PubMed ID: 25323535
[TBL] [Abstract][Full Text] [Related]
42. ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1.
Liu D; Skomorovska Y; Song J; Bowler E; Harris R; Ravasz M; Bai S; Ayati M; Tamai K; Koyuturk M; Yuan X; Wang Z; Wang Y; Ewing RM
Cancer Biol Ther; 2019; 20(1):90-100. PubMed ID: 30148686
[No Abstract] [Full Text] [Related]
43. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
44. ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC.
Wang H; Lin F; Xu Z; Yu S; Li G; Liao S; Zhao W; Zhang F; Wang J; Wang S; Ouyang C; Zhang C; Xia H; Wu Y; Jiang B; Li Q
Cell Mol Gastroenterol Hepatol; 2023; 16(4):541-556. PubMed ID: 37331567
[TBL] [Abstract][Full Text] [Related]
45. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
[TBL] [Abstract][Full Text] [Related]
47. Enhanced cytotoxicity of prenylated chalcone against tumour cells via disruption of the p53-MDM2 interaction.
Leão M; Soares J; Gomes S; Raimundo L; Ramos H; Bessa C; Queiroz G; Domingos S; Pinto M; Inga A; Cidade H; Saraiva L
Life Sci; 2015 Dec; 142():60-5. PubMed ID: 26475964
[TBL] [Abstract][Full Text] [Related]
48. ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression.
Chen Y; Lu X; Montoya-Durango DE; Liu YH; Dean KC; Darling DS; Kaplan HJ; Dean DC; Gao L; Liu Y
Sci Rep; 2017 Mar; 7(1):45. PubMed ID: 28246385
[TBL] [Abstract][Full Text] [Related]
49. WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma.
Sun Y; Bell JL; Carter D; Gherardi S; Poulos RC; Milazzo G; Wong JW; Al-Awar R; Tee AE; Liu PY; Liu B; Atmadibrata B; Wong M; Trahair T; Zhao Q; Shohet JM; Haupt Y; Schulte JH; Brown PJ; Arrowsmith CH; Vedadi M; MacKenzie KL; Hüttelmaier S; Perini G; Marshall GM; Braithwaite A; Liu T
Cancer Res; 2015 Dec; 75(23):5143-54. PubMed ID: 26471359
[TBL] [Abstract][Full Text] [Related]
50. MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Su L; Luo Y; Yang Z; Yang J; Yao C; Cheng F; Shan J; Chen J; Li F; Liu L; Liu C; Xu Y; Jiang L; Guo D; Prieto J; Ávila MA; Shen J; Qian C
Cancer Res; 2016 Sep; 76(17):5054-67. PubMed ID: 27364559
[TBL] [Abstract][Full Text] [Related]
51. p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells.
Parfenyev SE; Shabelnikov SV; Tolkunova EN; Barlev NA; Mittenberg AG
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372954
[TBL] [Abstract][Full Text] [Related]
52. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
53. Heterogeneous expression of zinc-finger E-box-binding homeobox 1 plays a pivotal role in metastasis via regulation of miR-200c in epithelial-mesenchymal transition.
Muto Y; Suzuki K; Kato T; Tsujinaka S; Ichida K; Takayama Y; Fukui T; Kakizawa N; Watanabe F; Saito M; Futsuhara K; Noda H; Miyakura Y; Konishi F; Rikiyama T
Int J Oncol; 2016 Sep; 49(3):1057-67. PubMed ID: 27315529
[TBL] [Abstract][Full Text] [Related]
54. Zeb1-mediated autophagy enhances resistance of breast cancer cells to genotoxic drugs.
Fedorova O; Daks A; Parfenyev S; Shuvalov O; Netsvetay S; Vasileva J; Gudovich A; Golotin V; Semenov O; Petukhov A; Baiduik E; Berdigaliyev N; Tulchinsky EM; Barlev NA
Biochem Biophys Res Commun; 2022 Jan; 589():29-34. PubMed ID: 34883287
[TBL] [Abstract][Full Text] [Related]
55.
Long ZH; Bai ZG; Song JN; Zheng Z; Li J; Zhang J; Cai J; Yao HW; Wang J; Yang YC; Yin J; Zhang ZT
Anticancer Res; 2017 Aug; 37(8):4345-4352. PubMed ID: 28739727
[TBL] [Abstract][Full Text] [Related]
56. Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles.
Cortés M; Sanchez-Moral L; de Barrios O; Fernández-Aceñero MJ; Martínez-Campanario MC; Esteve-Codina A; Darling DS; Győrffy B; Lawrence T; Dean DC; Postigo A
EMBO J; 2017 Nov; 36(22):3336-3355. PubMed ID: 29038174
[TBL] [Abstract][Full Text] [Related]
57. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
[TBL] [Abstract][Full Text] [Related]
58. ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM.
Zhang X; Zhang Z; Zhang Q; Zhang Q; Sun P; Xiang R; Ren G; Yang S
Cell Death Dis; 2018 Jan; 9(2):57. PubMed ID: 29352223
[TBL] [Abstract][Full Text] [Related]
59. Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.
Riscal R; Schrepfer E; Arena G; Cissé MY; Bellvert F; Heuillet M; Rambow F; Bonneil E; Sabourdy F; Vincent C; Ait-Arsa I; Levade T; Thibaut P; Marine JC; Portais JC; Sarry JE; Le Cam L; Linares LK
Mol Cell; 2016 Jun; 62(6):890-902. PubMed ID: 27264869
[TBL] [Abstract][Full Text] [Related]
60. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
